Strasbourg (France), January 14, 2025, 5:45 p.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces its financial reporting dates for 2025:
March 27, 2025: 2024 Fiscal Year Results
April 24, 2025: First Quarter 2025 Financial Results
May 15, 2025: Annual Shareholders' Meeting
September 16, 2025: First Half 2025 Financial Results
November 4, 2025: Third Quarter 2025 Financial Results
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer